| Literature DB >> 26958591 |
Georgios S E Antipas1, Anastasios E Germenis2.
Abstract
The tertiary structure of the native Cytomegalovirus peptide (NLV) presented by HLA-A2 and bound to the RA14 T cell receptor was used as a reference for the calculation of atomic coordination differences of both the NLV as well as of a number of singly substituted NLV variants in the absence of TCR. Among the pMHC complexes, the native peptide was found to exhibit the highest total coordination difference in respect to the reference structure, suggesting that it experienced the widest structural adaptation upon recognition by the TCR. In addition, the peptide on the isolated NLV-MHC complex was over-coordinated as compared to the rest of the variants. Moreover, the trend was found to account for a set of measured dissociation constants and critical concentrations for target-cell lysis for all variants in complexation with RA14: functionally, all variant peptides were established to be either weak agonists or null peptides, while, at the same time, our current study established that they were also under-coordinated in respect to NLV. It could, thus, be argued that the most 'efficient' structural adaptation upon pMHC recognition by the TCR requires of the peptide to undergo the widest under-coordination possible. The main structural characteristic which differentiated the NLV in respect to the variants was a the presence of 16 oxygen atoms (waters) in the former׳s second coordination shell which accounted for over-coordination of roughly 100% and 30% in the O-O and C-O partials respectively. In fact, in the absence of second shell oxygens, the NLV peptide was decidedly under-coordinated in respect to all of the variants, as also suggested by the C-C partial.Entities:
Keywords: CD8+ Cytotoxic lymphocytes; Class I MHC; Protein–protein interactions; pMHC-TCR interactions
Year: 2015 PMID: 26958591 PMCID: PMC4773413 DOI: 10.1016/j.dib.2015.07.019
Source DB: PubMed Journal: Data Brief ISSN: 2352-3409
Fig. 3Total and partial cumulative coordination differences between the unprotonated tertiary structures of each variant (Table 1) and the tertiary structure of the peptide on NLV-A2-RA14 complex (PDB ID 3GSN). All variants include second shell oxygen atoms. (a) Total coordination and coordination partials (b) C–C, (c) C–O and (d) O–O.
All peptides were loaded on HLA-A*0201.
| 3GSO | 3GSO_P | NLVPMVATV | 16 | 96 | 27.7 | 5.10−2 ±0.01 |
| 3GSV | 3GSV_P | NLVP | 6 | 3 | 57.5 | 102±20 |
| 3GSQ | 3GSQ_P | NLVP | 7 | – | n.b. | 5.102±20 |
| 3GSR | 3GSR_P | NLVP | 9 | 2 | 60.2 | 5.102±50 |
| 3GSU | 3GSU_P | NLVP | 9 | 3 | 58.2 | 103±30 |
| 3GSW | 3GSW_P | NLVPMVA | 7 | – | n.b. | >104 |
| 3GSX | 3GSX_P | NLVPMVA | 6 | 3 | n.b. | >104 |
All PDB entries listed refer to pMHC complexes. For each of the variants the amino acid substituted on the original NLV sequence (i.e. 3GSO_P) is underlined. Each peptide was surrounded by second coordination shell oxygen atoms (they are hence designated as ‘2nd shell O’ in the table). The number of different models arising for each peptide, due to substantial side-chain mobility during crystallization [11], is listed in the fifth table column. For 3GSO_P multiple positions involved the following atoms (notation is the atom species followed by its index in the PDB entry, multiple positions for the same species are separated by ‘/’): C36/C37, S38/S39, C40/C41 on residue 5, C47/C48/C49/C50 on residue 6, C63/C64 on residue 8 and O61/O62 on residue 8. 3GSV_P and 3GSV_P involved C57/C58 and O59/O60 on residue 8. Gras et al. [11] also measured the functional avidity of each of the variant pMHC complexes upon recognition by RA14 TCR (these pMHC-TCR structures were not crystallographed) and these values are presented as dissociation constants (KD) and peptide concentration necessary to achieve half maximal target-cell lysis (EC50) (notation ‘n.b.’ signifies that no pMHC-TCR binding was detected).
Fig. 1The stereochemistries of an indicative subset of peptides considered in the current study. In all peptides shown, second coordination shell oxygen atoms have been excluded. The peptides are (also see model designation in Table 2): A1 (3GSO_P), A4 (3GSQ_P), A5 (3GSR_P), A7 (3GSU_P), A10 (3GSV_P), A13 (3GSW_P) and A14 (3GSX_P). Reference peptide 3GSN_P is also shown.
Peptide models used in the coordination calculations.
| Peptide designation | Model | 2nd Shell O | |
|---|---|---|---|
| Excluded | Included | ||
| 3GSO_P | 36_38_40_49_48_63_61 | A1 | B1 |
| “ | 37_39_41_50_48_64_61 | A2 | B2 |
| “ | BLYP_TZ2P | A3 | B3 |
| 3GSQ_P | – | A4 | B4 |
| 3GSR_P | 56 | A5 | B5 |
| “ | 57 | A6 | B6 |
| 3GSU_P | 57_55 | A7 | B7 |
| “ | 58_55 | A8 | B8 |
| “ | 58_56 | A9 | B9 |
| 3GSV_P | 59_57 | A10 | B10 |
| “ | 60_57 | A11 | B11 |
| “ | 60_58 | A12 | B12 |
| 3GSW_P | – | A13 | B13 |
| 3GSX_P | 58_56 | A14 | B14 |
| “ | 58_57 | A15 | B15 |
| “ | 59_57 | A16 | B16 |
All models refer to peptide tertiary structure isolated from the pMHC complexes. Peptide designation follows from Table 1 and Model refers to the details given in the caption of Table 1. Model designation starts with ‘A’ and ‘B’ if second coordination shell oxygen atoms were included in and excluded from the structure, respectively.
Fig. 2Evolution of the difference between the cumulative total coordination for each of the variants which exhibited increased side-chain mobility, in respect to the native peptide. Coordination has been calculated for unprotonated structures excluding second shell O atoms. (a) Of the conformations possible for 3GSO_P, the two models which yielded the highest and lowest coordination in respect to the native peptide are shown. Additionally, coordination of the model for which side chain atoms were allowed to undergo DFT relaxation is included. (b), (c) and (d) Coordination differences of the three possible models for each of the 3GSV_P, 3GSU_P and 3GSX_P peptides respectively. In the graphs, the data series designation involves the indexes (as they appear in the original PDB entry) of the mobile side-chain atoms present in each model.
Specifications table
| Subject area | Immunology, biochemistry, materials science, quantum chemistry |
| More specific subject area | Class I MHC, CD8+ Cytotoxic lymphocytes, protein–protein interactions |
| Type of data | Excel spreadsheet |
| How data was acquired | Data from crystallized tertiary structures was acquired from the Protein Data Bank (PDB) |
| Data format | Text |
| Experimental factors | None |
| Experimental features | None |
| Data source location | Not applicable |
| Data accessibility | Data is with this article |